Frequency of somatic BRAF mutations in melanocytic lesions from patients in a CDK4 melanoma family

Pigment Cell and Melanoma Research

Volumn 27, Issue 1, 2014, Pages 149-151

  Puntervoll, Hanne E ^a   Molven, Anders ^a,b   Akslen, Lars A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; B RAF KINASE INHIBITOR; CYCLIN DEPENDENT KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CUTANEOUS MELANOMA; DYSPLASTIC NEVUS; G1 PHASE CELL CYCLE CHECKPOINT; GENE MUTATION; GENETIC DIFFERENCE; GENOTYPE; HUMAN; LETTER; MELANOMA; MULTICENTER STUDY (TOPIC); MUTATION RATE; SUN EXPOSURE;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CYCLIN-DEPENDENT KINASE 4; FAMILY; FEMALE; GENE FREQUENCY; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION, MISSENSE; NORWAY; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 84890801711     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12191     Document Type: Letter

References (15)

1. Curtin, J.A., Fridlyand, J., Kageshita, T., et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135-2147.
2. Curtin, J.A., Busam, K., Pinkel, D., et al. (2006). Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340-4346.
3. Eskandarpour, M., Hashemi, J., Kanter, L., et al. (2003). Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations. J. Natl Cancer Inst. 95, 790-798.
4. Greene, V.R., Johnson, M.M., Grimm, E.A., et al. (2009). Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma. J. Invest. Dermatol. 129, 1483-1488.
5. Jovanovic, B., Egyhazi, S., Eskandarpour, M., et al. (2010). Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations. J. Invest. Dermatol. 130, 618-620.
6. Lee, J.H., Choi, J.W., and Kim, Y.S. (2011). Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br. J. Dermatol. 164, 776-784.
7. Molven, A., Grimstvedt, M.B., Steine, S.J., et al. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosom. Cancer 44, 10-18.
8. Omholt, K., Platz, A., Kanter, L., et al. (2003). NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin. Cancer Res. 9, 6483-6488.
9. Platz, A., Egyhazi, S., Ringborg, U., et al. (2008). Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol. Oncol. 1, 395-405.
10. Pollock, P.M., Harper, U.L., Hansen, K.S., et al. (2003). High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19-20.
11. Poynter, J.N., Elder, J.T., Fullen, D.R., et al. (2006). BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res. 16, 267-273.
12. Puntervoll, H.E., Yang, X.R., Vetti, H.H., et al. (2013). Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J. Med. Genet. 50, 264-270.
13. Yancovitz, M., Litterman, A., Yoon, J., et al. (2012). Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PLoS ONE 7, e29336.
14. Zebary, A., Jangard, M., Omholt, K., et al. (2013a). KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Br. J. Cancer 109, 559-564.
15. Zebary, A., Omholt, K., Vassilaki, I., et al. (2013b). IT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. J. Dermatol. Sci. 72, 284-289.